What's Happening?
The Centers for Medicare & Medicaid Services (CMS) has released new data indicating a significant increase in out-of-network billing disputes proceeding to arbitration under the No Surprises Act. In the latter half of 2025, nearly 1.4 million disputes were
initiated, compared to 1.2 million in the first half of the year. This rise in disputes has been met with criticism from health insurers, who argue that the independent dispute resolution (IDR) process is being overwhelmed, leading to increased payments to providers. In 2025, providers received approximately $15 billion in IDR payouts, a substantial increase from $4.1 billion in 2024. The CMS data also reveals that payments determined through IDR are often higher than the qualifying payment amounts proposed by insurers. A small number of organizations are responsible for a large portion of these disputes, with companies like HaloMD and TeamHealth leading in the number of initiated disputes.
Why It's Important?
The surge in disputes under the No Surprises Act has significant implications for the U.S. healthcare system, particularly in terms of cost and regulatory challenges. The increase in arbitration cases and the resulting payouts to providers could lead to higher healthcare costs for consumers, as insurers may pass on these costs. The ongoing tension between providers and insurers highlights the complexities of the IDR process and the need for policy adjustments to address these issues. Insurers are calling for regulatory intervention to curb what they describe as 'provider-driven abuse' of the system, which they claim is contributing to wasteful spending and price gouging. The outcome of these disputes and the regulatory response will have a lasting impact on healthcare policy and the financial dynamics between providers and insurers.
What's Next?
CMS has recently finalized a rule aimed at reforming the IDR process, which includes batch determinations and an online portal for tracking disputes. While this rule has been welcomed by provider groups, insurers remain skeptical about its effectiveness in reducing the volume of disputes. The ongoing legal battles between insurers and providers, such as the recent case involving HaloMD, suggest that further court challenges and regulatory scrutiny are likely. Stakeholders in the healthcare industry will be closely monitoring the implementation of the new CMS rule and its impact on the IDR process. Additionally, there may be increased pressure on lawmakers to revisit the No Surprises Act and consider further legislative changes to address the concerns raised by insurers.
